Skip to main content
Clinical Trials/CTRI/2022/02/040385
CTRI/2022/02/040385
Not yet recruiting
未知

Coronally advanced flap with platelet rich fibrin or xenogeneic collagen matrix for the treatment of multiple adjacent gingival recession defects: A randomized clinical trial

Centre for Dental Education and Research All India Institute of Medical Sciences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: K055- Other periodontal diseases
Sponsor
Centre for Dental Education and Research All India Institute of Medical Sciences
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Centre for Dental Education and Research All India Institute of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • a)systemically healthy individuals
  • b)Healthy periodontium or demonstrating stable periodontal condition following conventional periodontal therapy
  • c)Full mouth plaque score (FMPS) and full mouth bleeding score (FMBS) of \< 15%
  • d)No history of previous periodontal surgery at experimental sites
  • e)Presence of at least two adjacent Cairo RT1 (gingival recession with no loss of interproximal attachment) multiple buccal recessions \>\= 2 mm on anterior teeth or premolars in both jaws
  • f)Presence of an identifiable CEJ (a step \<\=1 mm at CEJ level and/or presence of a root abrasion, but with an identifiable CEJ, will be accepted).
  • g)Probing depth (PD) \<\= 3 mm
  • h)Absence of non\-vital, supraerupted or mobile teeth for treatment of GR.

Exclusion Criteria

  • a)Molars and teeth with presence of restorations, caries or crowns in the area to be treated.
  • b)Gingival recessions presenting minimal amount ( \<1 mm) of keratinized tissue (KT) apical to recession area.
  • c)Pregnant and lactating females
  • d)Smokers or tobacco usage in any form
  • e)History of any systemic medication in last 3 months
  • f)Patients with coagulation disorders

Outcomes

Primary Outcomes

Not specified

Similar Trials